Category: SPMS-PPMS News

Featured image for “Press Release: Tolebrutinib phase 3 data published in NEJM demonstrate benefit on disability progression in multiple sclerosis”

Press Release: Tolebrutinib phase 3 data published in NEJM demonstrate benefit on disability progression in multiple sclerosis

Tolebrutinib phase 3 data published in NEJM demonstrate benefit on disability progression in multiple sclerosis Paris, April 8, 2025. The New…

Stuart Schlossman

What to Know About Multiple Sclerosis Progression in Chart Form

A more visual explanation of the progression of MS can be helpful for understanding your symptoms and the type of…

Stuart Schlossman

Featured image for “video: What is MS? Everything You Need to Know!”

video: What is MS? Everything You Need to Know!

Welcome to Aaron Boster MD, your trusted source for understanding Multiple Sclerosis (MS). * In this video, we dive deep…

Stuart Schlossman

Featured image for “International Workshop Focuses on Aging with Multiple Sclerosis”

International Workshop Focuses on Aging with Multiple Sclerosis

May 28, 2024 Almost half of all people living with MS today are 55 years of age or older, and…

Stuart Schlossman

Reasons Patients With Primary Progressive Multiple Sclerosis Contact Their Specialist Nurses

 Jacquelyn Bainbridge, PharmD; Rebecca Barnhart, PharmD; Ryan Fuller, PharmD; Van T. Hellerslia, PharmD; Julie Kidd, PharmD; Steven Merrill, PharmD; Emily…

Stuart Schlossman

Primary progressive MS confirmed as own disorder in mouse study

 Antibodies in spinal fluid seen to drive PPMS, but not relapsing MS by Marisa Wexler, MS | February 7, 2023…

Stuart Schlossman

Primary progressive MS confirmed as own disorder in mouse study

 by Marisa Wexler, MS | February 7, 2023 Antibodies in spinal fluid seen to drive PPMS, but not relapsing MS…

Stuart Schlossman

Large study finds greater risk of Infection with progressive forms than RRMS

 by Patricia Valerio, PhD | October 20, 2022 People with progressive forms of multiple sclerosis (MS) are nearly four times more likely…

Stuart Schlossman

Advances in Progressive Multiple Sclerosis

AAN Expert Exchange: Advances in Progressive Multiple Sclerosis June 22, 2022  Barry Hendin, MD, Regina Berkovich, MD, PhD, Ahmed Obeidat,…

Stuart Schlossman

New Research Finds That, For The First Time Ever, Stem Cell Treatments Improve Disability Status for Multiple Sclerosis Patients With Progressive Disease

 Preliminary analysis of FDA-approved study conducted by the Tisch MS Research Centerof New York found that stem cell treatments substantially improved…

Stuart Schlossman

Categories

Latest Blog Posts